June 25, 2026 Encouraging Clinical Responses in Early-Stage ER+HER2− Breast Cancer with Stereotactic Body Radiation and Immunotherapy
June 24, 2026 Retraction of Time-of-Day Immunochemotherapy Phase 3 Trial in Non-Small Cell Lung Cancer
May 16, 2026 Favipiravir vs Ribavirin for Lassa Fever: Phase 2 Trial Highlights Safety and Treatment Potential in Nigeria
April 17, 2026 Correction: Obicetrapib for Heterozygous Familial Hypercholesterolemia (BROOKLYN Trial)
April 15, 2026 Elraglusib Plus Gemcitabine and Nab-Paclitaxel Prolongs Survival in Metastatic Pancreatic Cancer